Lilly withdraws from EU rolling review of Covid-19 antibodies
Lilly's letter to the European Medicines Agency (EMA), dated Oct. 29, said that "at this point Lilly is not in a position to generate the additional data required by the CHMP (EMA's...
Lilly's letter to the European Medicines Agency (EMA), dated Oct. 29, said that "at this point Lilly is not in a position to generate the additional data required by the CHMP (EMA's...